Key facts
- This page summarizes Choo Chee Kong's Form 4 filing for CytoMed Therapeutics Ltd (GDTC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 15 Jun 2026, 06:15.
Choo Chee Kong - 08 Jun 2026 Form 4 Insider Report for CytoMed Therapeutics Ltd (GDTC)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- GDTC
- Reported as of
- 08 Jun 2026
- Net transaction value
- +$128,778
- SEC form
- 4
- Accepted by SEC
- 15 Jun 2026, 06:15:26 UTC
- Prior SEC filing
- 15 May 2026
- Next SEC filing
- 24 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Chee Kong Choo
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Choo Chee Kong filed Form 4 for CytoMed Therapeutics Ltd (GDTC) on 15 Jun 2026.
Change
- Previous filing in this sequence was filed on 15 May 2026.
- Current net transaction value: +$128,778.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001970632
Primary reporting owner
Choo Chee Kong
- Relationship
- Director, 10%+ Owner
- Address
- 1 COMMONWEALTH LANE #08-22,, SINGAPORE, SINGAPORE
- Signature
- /s/ Chee Kong Choo
- Signature date
- 15 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GDTC
transaction
Ordinary Shares, no par value per share
Purchase
- Transaction value
- $128,778
- Shares
- +112,000
- Change %
- +35%
- Price
- $1.15
- Shares after
- 430,324
- Date
- 13 May 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.